Cargando…
Vascular wall proteoglycan synthesis and structure as a target for the prevention of atherosclerosis
Atherosclerosis is the underlying pathology of most cardiovascular disease and it represents the major cause of premature death in modern societies. Current therapies target risk factors being hypertension, hypercholesterolemia, hypertriglyceridemia and hyperglycemia when diabetes is present however...
Autores principales: | Little, Peter J, Ballinger, Mandy L, Osman, Narin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994044/ https://www.ncbi.nlm.nih.gov/pubmed/17583182 |
Ejemplares similares
-
Actions of Calcium Channel Blockers on Vascular Proteoglycan Synthesis: Relationship to Atherosclerosis
por: Survase, Soniya, et al.
Publicado: (2005) -
Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo
por: Ballinger, Mandy L, et al.
Publicado: (2010) -
Androgens: New Effects on Proteoglycan Biosynthesis and Its Consequences for Atherosclerosis
por: Sudhir, Krishnankutty, et al.
Publicado: (2005) -
New Approaches to Regulating the Chondroitin/Dermatan Sulfate Glycosaminoglycan Component of the Vascular Extracellular Matrix
por: Nigro, Julie, et al.
Publicado: (2005) -
Cellular and Molecular Pathology of Age-Related Macular Degeneration: Potential Role for Proteoglycans
por: Al Gwairi, Othman, et al.
Publicado: (2016)